Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-24 @ 7:02 PM
NCT ID:
NCT04822857
Eligibility Criteria:
Inclusion Criteria:
About 100 women aged\> 40 years will be included in the study with diagnosed pharmacologically controlled hypertension, including:
Group I-about 50 women \> 40 years before the onset of menopause Group II - approximately 50 women \> 1 year after the onset of menopause
Exclusion Criteria:
unstable hypertension;
* diagnosed heart failure or typical symptoms of heart failure;
* documented: hyperandrogenism, hyperendogenism, insulin resistance, premature ovarian failure, polycystic ovary syndrome;
* previous myocardial infarction;
* diagnosed cardiomyopathy (hypertrophic, dilated, restrictive, puerperal, tachyarrhythmic);
* storage diseases;
* stroke, TIA, an intracerebral bleeding;
* severe hyperthyroidism or hypothyroidism;
* pregnancy or lactation;
* chronic kidney disease in stage IV, V according to NKF and patients undergoing dialysis;
* documented cancer process;
* patient's inability to cooperate and / or give informed consent not to participate in a research;
* alcohol and drug abuse;
* active autoimmune disease;
* taking immunosuppressive, cytostatic drugs, glucocorticoids or antiretroviral drugs;
* bone marrow transplant or other organ transplantation, treatment with blood products during the last 6 months;
* active systemic infection;
* HBV, HCV or HIV infection or a positive result for the presence of HbS antigen or anti-HCV antibodies;
* surgery or serious injury in the last month;
* vaccination interview in the last 3 months;
* patients who have not expressed their informed consent to participate in the study
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
40 Years
Study:
NCT04822857
Study Brief:
Protocol Section:
NCT04822857